Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heron Therapeutics Inc (HRTX)

Logo korporat perusahaan Heron Therapeutics, Inc. (HRTX)

The recruitment of top-tier oncology and pain therapy specialists has served as a growth catalyst for Heron Therapeutics (HRTX). The historical trend of next year's EPS forecasts on the GURU.Markets time chart confirms this trajectory, where the 11.30 level reflects the current magnitude. This has enabled the establishment of strict temperature control during drug delivery and the complete transition of production to external outsourcing.

Heron Therapeutics Inc (HRTX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 18.11.2026

Ringkesan rincian data analitis Heron Therapeutics (HRTX)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Heron
Produk dadi Heron Therapeutics Inc

To assess the long-term risks of Heron Therapeutics (HRTX), the earnings per share growth forecast, which reflects analyst consensus expectations for future returns, is critically important. This indicator measures the expected EPS dynamics, stripping fundamental value from market speculation. By analyzing the trend of earnings per share growth forecasts, an investor can discern the speed at which the business adapts to new challenges. The stability of the healthcare sector and a neutral geopolitical backdrop support the resilience of this metric.

Analisis pesaing Heron Therapeutics

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|Inhibrx Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals|NVCT: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Coherus CHRS|Prakiraan wutah bathi saben saham kanggo taun ngarep CRBP|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardiff Oncology CRDF|Prakiraan wutah bathi saben saham kanggo taun ngarep BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Lixte Biotechnology - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep CTXR (Citius Pharma)|Cellectar - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BLRX (BioLineRx Corp)|CANF: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aprea (APRE)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kaziatherapeutics.com|SLXN: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep NCNA|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)